191 related articles for article (PubMed ID: 32914231)
1. [The microbiome in benign prostatic hyperplasia].
Magistro G; Füllhase C; Stief CG; Bschleipfer T
Urologe A; 2020 Oct; 59(10):1204-1207. PubMed ID: 32914231
[TBL] [Abstract][Full Text] [Related]
2. [The role of the microbiome in urology].
Magistro G; Marcon J; Eismann L; Volz Y; Stief CG
Urologe A; 2020 Dec; 59(12):1463-1471. PubMed ID: 33044634
[TBL] [Abstract][Full Text] [Related]
3. The Urinary Tract Microbiome: The Answer to All Our Open Questions?
Magistro G; Stief CG
Eur Urol Focus; 2019 Jan; 5(1):36-38. PubMed ID: 30042043
[TBL] [Abstract][Full Text] [Related]
4. [The role of the microbiome in urological diseases].
Atzler M; Westhofen T; Tamalunas A; Schott M; Keller P; Ebner B; Stief C; Magistro G
Aktuelle Urol; 2021 Aug; 52(4):338-344. PubMed ID: 34102684
[TBL] [Abstract][Full Text] [Related]
5. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.
Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM
J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134
[TBL] [Abstract][Full Text] [Related]
6. Effects of inflammatory prostatitis on the development and progression of benign prostatic hyperplasia: A literature review.
Tsunemori H; Sugimoto M
Int J Urol; 2021 Nov; 28(11):1086-1092. PubMed ID: 34342061
[TBL] [Abstract][Full Text] [Related]
7. Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
Chiang BJ; Kuo HC; Liao CH
Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31546892
[TBL] [Abstract][Full Text] [Related]
8. The Urinary Tract Microbiome in Health and Disease.
Aragón IM; Herrera-Imbroda B; Queipo-Ortuño MI; Castillo E; Del Moral JS; Gómez-Millán J; Yucel G; Lara MF
Eur Urol Focus; 2018 Jan; 4(1):128-138. PubMed ID: 28753805
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary approach to prostatitis.
Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
[TBL] [Abstract][Full Text] [Related]
10. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis.
Nickel JC
Curr Opin Urol; 2006 Jan; 16(1):5-10. PubMed ID: 16385194
[TBL] [Abstract][Full Text] [Related]
11. The microbiome in prostate inflammation and prostate cancer.
Porter CM; Shrestha E; Peiffer LB; Sfanos KS
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):345-354. PubMed ID: 29795140
[TBL] [Abstract][Full Text] [Related]
12. The role of prostatic inflammation in the development and progression of benign and malignant diseases.
Gandaglia G; Zaffuto E; Fossati N; Cucchiara V; Mirone V; Montorsi F; Briganti A
Curr Opin Urol; 2017 Mar; 27(2):99-106. PubMed ID: 27906778
[TBL] [Abstract][Full Text] [Related]
13. Dying for love: Perimenopausal degeneration of vaginal microbiome drives the chronic inflammation-malignant transformation of benign prostatic hyperplasia to prostatic adenocarcinoma.
Reece AS
Med Hypotheses; 2017 Apr; 101():44-47. PubMed ID: 28351489
[TBL] [Abstract][Full Text] [Related]
14. The Role of Urinary Microbiota in Lower Urinary Tract Dysfunction: A Systematic Review.
Antunes-Lopes T; Vale L; Coelho AM; Silva C; Rieken M; Geavlete B; Rashid T; Rahnama'i SM; Cornu JN; Marcelissen T;
Eur Urol Focus; 2020 Mar; 6(2):361-369. PubMed ID: 30270128
[TBL] [Abstract][Full Text] [Related]
15. [The effectiveness of the integrated approach to the treatment of chronic prostatitis, including in patients with benign prostatic hyperplasia].
Zhiborev AB; Martov AG
Urologiia; 2018 Oct; (4):81-87. PubMed ID: 30761794
[TBL] [Abstract][Full Text] [Related]
16. Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.
Hu J; Zhang L; Zou L; Hu M; Fan J; Cai Y; Xu G; Fang J; Ding Q; Jiang H
Int J Urol; 2015 Dec; 22(12):1138-42. PubMed ID: 26311564
[TBL] [Abstract][Full Text] [Related]
17. Urinary microbiota and prostatic diseases: the key for the lock? A systematic review.
Mjaess G; Karam A; Roumeguère T; Diamand R; Aoun F; McVary K; Moul JW; De Nunzio C; Albisinni S
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):451-460. PubMed ID: 36209236
[TBL] [Abstract][Full Text] [Related]
18. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).
Gandaglia G; Briganti A; Gontero P; Mondaini N; Novara G; Salonia A; Sciarra A; Montorsi F
BJU Int; 2013 Aug; 112(4):432-41. PubMed ID: 23650937
[TBL] [Abstract][Full Text] [Related]
19. The Association of Prostate Cancer and Urinary Tract Infections: A New Perspective of Prostate Cancer Pathogenesis.
Pan SY; Chen WC; Huang CP; Hsu CY; Chang YH
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984484
[No Abstract] [Full Text] [Related]
20. [Application of saw palmetto fruit extract in the treatment of prostate diseases].
Zhan XX; Shang XJ; Huang YF
Zhonghua Nan Ke Xue; 2015 Sep; 21(9):841-6. PubMed ID: 26552220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
